Petrie-Flom Intern’s Weekly Round-Up, 3/28-4/4

By Chloe Reichel

In an attempt to increase transparency and accountability of Medicare, the Obama administration will release data about the services provided as a part of this program. The information will focus on the number and kind of services provided.

In the six months following the implementation of the Affordable Care Act, over seven million Americans signed up for insurance plans. These figures are in accordance with those estimated by congressional budget analysts.

Teva Pharmaceutical Industries has appealed a case to the Supreme Court about a generic form of its drug Copaxone. Teva is trying to keep their patent on the drug to prevent the manufacture of generics.

Judge David C. Bury, a federal judge in Tucson, will not stop the implementation of rules that restrict the usage of the abortion drug mifepristone in the state of Arizona. The legislation that restricted the usage of this drug went into effect on Tuesday.

On Monday, the last day for sign ups for health insurance plans under the Affordable Care Act, hundreds of thousands attempted to register for policies. The website HealthCare.gov had some glitches on this day, including a period of a few hours in which the site failed to accept applications.

The Affordable Care Act has allowed many Americans who were previously uninsured to sign up for health insurance, leading to increased usage of health services. This is creating new stresses for small health clinics, but also providing additional funds that allow these clinics to operate.

On Thursday the FDA approved a handheld antidote for painkiller overdoses. The naloxone device, made by kaleo Inc., is called Evzio.

An ethics report was recently released on the risks of long-term space travel. The report addresses physical and psychological risks associated with space travel.

Be Sociable, Share!